Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | SNV | Common Stock | Tax liability | -$15.1K | -288 | -2.1% | $52.43 | 13.4K | Feb 18, 2022 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | SNV | Performance Stock Units | Award | $0 | +4.86K | +67.88% | $0.00 | 12K | Feb 17, 2022 | Common Stock | 4.86K | Direct | F2 | |
transaction | SNV | Restricted Stock Units | Award | $0 | +3.24K | $0.00 | 3.24K | Feb 17, 2022 | Common Stock | 3.24K | Direct | F3 |
Id | Content |
---|---|
F1 | These shares were withheld upon the vesting of restricted stock units to pay tax withholding obligations. |
F2 | These shares are subject to performance stock units (the "PSUs"). The PSUs have a service-based vesting component as well as a performance vesting requirement. Under the service-based vesting component, the PSUs vest 100% after three years subject to the reporting person's continued employment with Synovus. Under the performance vesting component, two performance measures (weighted average return on tangible common equity and relative total shareholder return) are measured over a three-year performance period, with each measure impacting one-half of the PSUs awarded to the reporting person. The actual payout of the PSUs may range from 0% to 150% of the target amount based upon the results of the two performance measures during the performance period compared to the performance objective approved by the Compensation and Human Capital Committee of Synovus' Board of Directors. |
F3 | These shares are subject to restricted stock units that will be settled in cash upon vesting. The units vest 1/3 each year over a three-year period subject to the reporting person's continued employment with Synovus. |